Pankaj Gupta - Publications, H-index & Citations

Pankaj Gupta

Department of Biotechnology

23H指数

117论文数

3.2K被引数

收录论文 23

发表时间

Dual Ampullary Orifices: A Forgotten Embryologic Anomaly in Modern ERCP 双壶腹开口：现代ERCP中易被忽视的胚胎学异常

ACG Case Reports Journal

IF0

2026-05-01

PREAI

Gupta, Pankaj; Singh, Pankaj; Singla, Vikas; Shawl, Muzzaffar Rashid; Goel, Akash

Advanced Nanoparticle-Based strategies for plant viral disease management: mechanisms and innovations for crop protection 基于纳米粒子的植物病毒病管理高级策略：作物保护的机制与创新

3 Biotech

IF2.9

2025-11-22

PREAI

Manoj Kumar Mishra; Rishabh Anand Omar; Vivek Srivastava; Shilpy Singh; Ved Vrat Verma; Pankaj Gupta; Sanjay Mishra; Varun Kumar Sharma

Creating multifaceted allied health professionals with skilled hands and the power of words 培养具备娴熟技艺与沟通能力的多元化卫生专业人才

Frontiers in Medicine

IF3

2025-11-10

OAAI

Urmila Kagal†; Sharmila Jalgaonkar; Pankaj Gupta; Nayana Hashilkar

RETRACTION: Bacopa monnieri attenuates glutamate-induced nociception and brain mitochondrial toxicity in zebrafish (Retraction of Vol 37, Pg 383, 2021)

METABOLIC BRAIN DISEASE

IF3.5

2023-09-02

OAAI

Sharma, Mahima; Gupta, Pankaj; Garabadu, Debapriya

RETRACTED: Bacopa monnieri attenuates glutamate-induced nociception and brain mitochondrial toxicity in Zebrafish (Retracted Article)

METABOLIC BRAIN DISEASE

IF3.5

2021-11-24

PREAI

Sharma, Mahima; Gupta, Pankaj; Garabadu, Debapriya

Kinetic-Pharmacodynamic Model of Platelet Time Course in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Oral Janus Kinase 1 Inhibitor Abrocitinib

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2020-09-22

OAAI

Soto, Elena; Banfield, Christopher; Gupta, Pankaj; Peterson, Mark C.

Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator's Global Assessment and Eczema Area and Severity Index

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2019-09-01

OAAI

Deng, C.; Xie, R.; Banfield, C.; Gupta, P.; Feeney, C.; Rojo, R.; Peterson, M. C.

The precision of case difficulty and referral decisions: an innovative automated approach

CLINICAL ORAL INVESTIGATIONS

IF3.1

2019-08-13

PREAI

Mallishery, Shivani; Chhatpar, Pavan; Banga, K. S.; Shah, Trusha; Gupta, Pankaj

Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2018-10-10

OAAI

Strober, B. E.; Gottlieb, A. B.; van de Kerkhof, P. C. M.; Puig, L.; Bachelez, H.; Chouela, E.; Imafuku, S.; Thaci, D.; Tan, H.; Valdez, H.; Gupta, P.; Kaur, M.; Frajzyngier, V.; Wolk, R.

Harnessing the Potential of Emerging Digital Health and Biological Sampling Technologies for Clinical Drug Development: Promise to Reality

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2018-06-19

PREAI

Kothare, Prajakti A.; Jadhav, Pravin R.; Gupta, Pankaj; Harrelson, Jane Croft; Dickmann, Leslie

Herpes zoster in psoriasis patients treated with tofacitinib

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2017-08-01

PREAI

Winthrop, Kevin L.; Lebwohl, Mark; Cohen, Arnon D.; Weinberg, Jeffrey M.; Tyring, Stephen K.; Rottinghaus, Scott T.; Gupta, Pankaj; Ito, Kaori; Tan, Huaming; Kaur, Mandeep; Egeberg, Alexander; Mallbris, Lotus; Valdez, Hernan

Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2017-06-21

OAAI

Checchio, T.; Ahadieh, S.; Gupta, P.; Mandema, J.; Puig, L.; Wolk, R.; Valdez, H.; Tan, H.; Krishnaswami, S.; Tallman, A.; Kaur, M.; Ito, K.

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2016-05-01

127

OAAI

Papp, Kim A.; Krueger, James G.; Feldman, Steven R.; Langley, Richard G.; Thaci, Diamant; Torii, Hideshi; Tyring, Stephen; Wolk, Robert; Gardner, Annie; Mebus, Charles; Tan, Huaming; Luo, Yingchun; Gupta, Pankaj; Mallbris, Lotus; Tatulych, Svitlana

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials Tofacitinib，一种口服Janus激酶抑制剂，用于治疗慢性斑块状银屑病: 两项随机，安慰剂对照，III期试验的结果

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2015-10-29

255

OAAI

Papp, K. A.; Menter, M. A.; Abe, M.; Elewski, B.; Feldman, S. R.; Gottlieb, A. B.; Langley, R.; Luger, T.; Thaci, D.; Buonanno, M.; Gupta, P.; Proulx, J.; Lan, S.; Wolk, R.

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

LANCET

IF88.5

2015-08-01

336

PREAI

Bachelez, Herve; van de Kerkhof, Peter C. M.; Strohal, Robert; Kubanov, Alexey; Valenzuela, Fernando; Lee, Joo-Heung; Yakusevich, Vladimir; Chimenti, Sergio; Papacharalambous, Jocelyne; Proulx, James; Gupta, Pankaj; Tan, Huaming; Tawadrous, Margaret; Valdez, Hernan; Wolk, Robert

Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2015-05-01

121

PREAI

Bissonnette, R.; Iversen, L.; Sofen, H.; Griffiths, C. E. M.; Foley, P.; Romiti, R.; Bachinsky, M.; Rottinghaus, S. T.; Tan, H.; Proulx, J.; Valdez, H.; Gupta, P.; Mallbris, L.; Wolk, R.

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2012-08-27

284

PREAI

Papp, K. A.; Menter, A.; Strober, B.; Langley, R. G.; Buonanno, M.; Wolk, R.; Gupta, P.; Krishnaswami, S.; Tan, H.; Harness, J. A.

Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: confirmation of in vitro data

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2012-06-11

OAAI